BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31397922)

  • 1. Role of the arecoline/YAP1/BMP4 pathway in promoting endothelial-mesenchymal transition in oral submucous fibrosis.
    Yao M; Li J; Yuan S; Zhu X; Hu Z; Li Q; Cao R; Wang W; Fang C
    J Oral Pathol Med; 2020 Apr; 49(4):305-310. PubMed ID: 31397922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP-Induced Endothelial-Mesenchymal Transition in Oral Submucous Fibrosis.
    Li J; Yao M; Zhu X; Li Q; He J; Chen L; Wang W; Zhu C; Shen T; Cao R; Fang C
    J Dent Res; 2019 Jul; 98(8):920-929. PubMed ID: 31282845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Notch Suppresses Epithelial-mesenchymal Transition and Induces Angiogenesis in Oral Submucous Fibrosis by Regulating TGF-β1.
    Wang J; Yang L; Mei J; Li Z; Huang Y; Sun H; Zheng K; Kuang H; Luo W
    Biochem Genet; 2024 Apr; 62(2):1055-1069. PubMed ID: 37526864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-203 inhibits arecoline-induced epithelial-mesenchymal transition by regulating secreted frizzled-related protein 4 and transmembrane-4 L six family member 1 in oral submucous fibrosis.
    Zheng L; Jian X; Guo F; Li N; Jiang C; Yin P; Min AJ; Huang L
    Oncol Rep; 2015 Jun; 33(6):2753-60. PubMed ID: 25872484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
    Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
    J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
    Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
    Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDE12 disrupts mitochondrial oxidative phosphorylation and mediates mitochondrial dysfunction to induce oral mucosal epithelial barrier damage in oral submucous fibrosis.
    Wei Q; Chen L; Luo W; Chen C; Shi Y; Xie J; Xie X; Luo HB
    Eur J Pharmacol; 2024 Mar; 967():176353. PubMed ID: 38325798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of DEC1 in the epithelium of OSF promotes mesenchymal transition via activating FAK/Akt signal axis.
    Hu X; Wang W; Hu Y; Chen W; Wang C; Yang L; Mao T; Xia K; Min A; Xiong H; Su T
    J Oral Pathol Med; 2022 Oct; 51(9):780-790. PubMed ID: 36053880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
    Shieh DH; Chiang LC; Shieh TY
    Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
    Yu CC; Tsai CH; Hsu HI; Chang YC
    PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
    Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
    J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline.
    Tsai CH; Lee SS; Chang YC
    J Oral Pathol Med; 2015 Oct; 44(9):669-73. PubMed ID: 25367145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
    Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
    J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.
    Lee SS; Chen YJ; Tsai CH; Huang FM; Chang YC
    Clin Oral Investig; 2016 Jun; 20(5):1029-34. PubMed ID: 26336810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
    Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
    J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slug mediates myofibroblastic differentiation to promote fibrogenesis in buccal mucosa.
    Fang CY; Hsia SM; Hsieh PL; Liao YW; Peng CY; Wu CZ; Lin KC; Tsai LL; Yu CC
    J Cell Physiol; 2019 May; 234(5):6721-6730. PubMed ID: 30230545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrotic Matrix Induces Mesenchymal Transformation of Epithelial Cells in Oral Submucous Fibrosis.
    Xu HQ; Guo ZX; Yan JF; Wang SY; Gao JL; Han XX; Qin WP; Lu WC; Gao CH; Zhu WW; Fu YT; Jiao K
    Am J Pathol; 2023 Sep; 193(9):1208-1222. PubMed ID: 37328100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jiawei Danxuan Koukang Alleviates Arecoline Induced Oral Mucosal Lesions: Network Pharmacology and the Combined Ultra-High Performance Liquid Chromatography (UPLC) and Mass Spectrometry (MS).
    Zhou L; Tan J; Dai Y; Zhu K; Xiao Y; Wu D; Wang Z; Tan Y; Qin Y
    Drug Des Devel Ther; 2023; 17():3085-3101. PubMed ID: 37854130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of autophagy and apoptosis in atrophic epithelium in oral submucous fibrosis.
    Zhu B; Jiang Q; Que G; Dai Z; Wu Y
    J Oral Sci; 2020 Mar; 62(2):184-188. PubMed ID: 32132327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
    Liao YW; Yu CC; Hsieh PL; Chang YC
    J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.